Understanding recent increases in chronic disease treatment rates: More disease or more detection?

Health Economics, Policy and Law

Volumn 5, Issue 4, 2010, Pages 411-435

  Howard, David H ^a   Thorpe, Kenneth E ^a   Busch, Susan H ^b  

^a EMORY UNIVERSITY   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE REGISTRY; DRUG INDUSTRY; DRUG MARKETING; HEALTH CARE COST; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; LUNG DISEASE; MALIGNANT NEOPLASTIC DISEASE; MEDICARE; MORBIDITY; MORTALITY; OBESITY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; STEADY STATE; SURVIVAL TIME; UNITED STATES;

CHRONIC DISEASE; DIABETES MELLITUS; HUMANS; INCIDENCE; MENTAL DISORDERS; NEOPLASMS; OBESITY; PREVALENCE; RISK FACTORS; WORLD HEALTH;

EID: 79451470807     PISSN: 17441331     EISSN: 1744134X     Source Type: Journal    
DOI: 10.1017/S1744133110000149     Document Type: Article

References (26)

1. Berry, D. A., K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. F. Habbema and E. J. Feuer, For the Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005), Effect of screening and adjuvant therapy on mortality from breast cancer, New England Journal of Medicine, 353:1784-1792.
2. Burt, V. L., J. A. Cutler, M. Higgins, M. J. Horan, D. Labarthe, P. Whelton, C. Brown and E. J. Roccella (1995), 'Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population data from the Health Examination Surveys, 1960 to 1991', Hypertension, 26(1):60-69.
3. Cawley, J. and R. V. Burkhauser (2006), Beyond BMI: The Value of More Accurate Measures of Fatness and Obesity in Social Science Research. NBER Working Paper 12291.
4. Cohen, J. W. and N. A. Krauss (2003), 'Spending and service use among people with the fifteen most costly medical conditions, 1997', Health Affairs, 22(2):129-138.
5. Conrad, P. (2005), 'The shifting engines of medicalization', Journal of Health and Social Behavior, 46:3-14.
6. Critser, G. (2005), Generation Rx. How Prescription Drugs Are Altering American Lives, New York: Houghton Mifflin Company.
7. Cutler, D. M. and E. Meara (2000), 'The technology of birth: is it worth it?', Frontiers in Health Policy Research, Article 3. http://www.bepress.com/ Fhep/3/3/
8. Cutler, D. M., M. McClellan, J. P. Newhouse and D. Remler (1998), 'Are medical prices falling?', Quarterly Journal of Economics, 113(4):991-1024.
9. Etzioni, R., K. M. Berry, J. M. Legler and P. Shaw (2002), 'Prostate-specific antigen testing in black and white men: an analysis of Medicare claims from 1991-1998', Urology, 59:251-255.
10. Fairlie, R. W. (2005), 'An extension of the Blinder-Oaxaca decomposition technique to logit and probit models', Journal of the Economic and Social Measurement, 3:305-316.
11. Field, A. E., E. H. Coakley, A. Must, J. L. Spadano, N. Laird, W. H. Dietz, E. Rimm and G. A. Colditz (2001), 'Impact of overweight on the risk of developing common chronic diseases during a ten-year period', Archives of Internal Medicine, 161(13):1581-1586.
12. Flegal, K. M., M. D. Carroll, C. L. Ogden and C. L. Johnson (2002), 'Prevalence and trends in obesity among US adults, 1999-2000', Journal of the American Medical Association, 288:1723-1727.
13. Grossman, G. M. and C. Shapiro (1984), 'Informative advertising with differentiated products', Review of Economic Studies, 5(1):63-81.
14. Gregg, E. W., Y. J. Cheng and B. L. Cadwell, et al. (2005), 'Secular trends in cardiovascular disease risk factors according to body mass index in US adults', Journal of the American Medical Association, 293(15):1868-1874.
15. Herndon, M. B., L. M. Schwartz, S. Woloshin and H. G. Welch (2007), 'Implications of expanding disease definitions: the case of osteoporosis', Health Affairs, 26(6):1702-1711.
16. Iizuka, T. (2004), 'What explains the use of direct-to-consumer advertising of prescription drugs?', The Journal of Industrial Economics, LII (3):349-379.
17. Kaplan, R. M. and M. Ong (2007), 'Rationale and public health implications of changing CHD risk factor definitions', Annual Review of Public Health, 28:321-344.
18. Klawiter, M. (2005), 'The Biopolitics of Risk and the Configuration of Users: Clinical Trials, Pharmaceutical Technologies, and the New Consumption-Junction', in S. Frickel and K. Moore (eds), The New Political Sociology of Science: Institutions, Networks, and Power, Madison, WI: University of Wisconsin Press.
19. Legorreta, A. P., J. H. Silber, G. N. Costantino, R. W. Kobylinski and S. L. Zatz (1993), 'Increased cholecystectomy rate after the introduction of laparoscopic cholecystectomy', Journal of the American Medical Association, 270(12):1429-1432.
20. Moynihan, R. and A. Cassels (2005), Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All into Patients, NY: Nation Books.
21. Must, A., J. Spadano, E. H. Coakley, A. E. Field, G. Colditz and W. H. Dietz (1999), 'The disease burden associated with overweight and obesity', Journal of the American Medical Association, 282(16):1523-1529.
22. National Center for Health Statistics 2006. Health, United States, 2006, with Chartbook on Trends in the Health of Americans. Hyattsville, MD.
23. Rosenthal, M. B., E. R. Berndt, J. M. Donohue, A. M. Epstein and R. G. Frank (2003), 'Demand Effects of Recent Changes in Prescription Drug Promotion', in Frontiers in Health Policy Research, Cambridge and London: MIT Press for the National Bureau of Economic Research 6:1-26.
24. Schenthal, J. E. (1960), 'Multiphasic screening of the well patient', Journal of the American Medical Association, 172(1):51-54.
25. Schwartz, L. M. and S. Woloshin (1999), 'Changing disease definitions: implications for disease prevalence. Analysis of the Third National Health and Nutrition Examination Survey, 1988-1994', Effective Clinical Practice, 2:76-85.
26. Thorpe, K. E., C. S. Florence, D. H. Howard and P. Joski (2005), 'The impact of rising disease prevalence on private health insurance spending', Health Affairs, 5: w317-w325.